NAV
$43.28
AUM
$165.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.84
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| - | - | - | - | +12.29% | +5.92% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | BN.TO | Brookfield Corp Registered Shs -A- Limited Vtg | 6.22% |
| 2 | FNV.TO | Franco-Nevada Corp | 4.72% |
| 3 | MCK | McKesson Corp | 4.47% |
| 4 | 005930.KS | Samsung Electronics Co Ltd | 4.22% |
| 5 | NVS | Novartis AG ADR | 4.03% |
| 6 | UNP | Union Pacific Corp | 4.03% |
| 7 | MSFT | Microsoft Corp | 3.92% |
| 8 | AZN | AstraZeneca PLC ADR | 3.87% |
| 9 | HEINY | Heineken NV ADR | 3.77% |
| 10 | FISV | Fiserv Inc | 3.50% |
The fund primarily invests in U.S. and non-U.S. equity securities that the Adviser believes have significantly more appreciation potential than downside risk over the long term. Equity securities in which the fund may invest include, but are not limited to, common and preferred stock of companies of all size market capitalizations, rights and warrants. Under normal circumstances, the fund will invest at least 40% of its total assets in non-U.S. securities. During unusual market conditions, the fund will invest at least 30% of its total assets in non-U.S. securities.
Inception Date: 2014-10-14